GBP1 and neoplasm: The anti-tumor activity of GBP-1 was first highlighted by the finding that cytokine-induced inhibition of angiogenic growth factor-induced proliferation of cultured human endothelial cells (HUVECs) resulted in the expression of GBP-1 [29,30].